HIV prevention drug : billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019.
Editor: Washington : U.S. Government Publishing Office, 2019Descripción: iii, 63 pages ; 24 cmTipo de contenido:- Human Immunodeficiency Virus prevention drug
- Billions in corporate profits after millions in taxpayer investments
- Gilead Sciences (Firm)
- Pre-exposure prophylaxis -- Prices -- United States
- Pre-exposure prophylaxis -- United States -- Cost control
- HIV infections -- United States -- Prevention
- Prescription pricing -- Government policy -- United States
- Pharmaceutical industry -- Prices -- Government policy -- United States
- Medical policy -- United States
- Federal aid to medical research -- United States
- KF27 .O96 2019i
| Imagen de cubierta | Tipo de ítem | Biblioteca actual | Biblioteca de origen | Colección | Ubicación en estantería | Signatura topográfica | Materiales especificados | Info Vol | URL | Copia número | Estado | Notas | Fecha de vencimiento | Código de barras | Reserva de ítems | Prioridad de la cola de reserva de ejemplar | Reservas para cursos | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recurso en Internet | Biblioteca de Derecho Mons. Fremiot Torres Oliver Online | Y 4.OV 2:116-24 (Navegar estantería(Abre debajo)) | Disponible | Y 4.OV 2:116-24//ON; |
Total de reservas: 0
"Serial no. 116-24."
Shipping list no.: 2020-0010-M.
GPO Cataloging Record Distribution Program (CRDP).
Microfiche. [Washington, D.C.] : U.S. Government Printing Office, [2019] 1 microfiche : negative.